Therapeutic Drug Monitoring - Targeting IMproved Effectiveness

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

December 12, 2023

Primary Completion Date

June 21, 2024

Study Completion Date

June 21, 2024

Conditions
PneumoniaSepsisInfection, Bacterial
Interventions
OTHER

No intervention

No intervention

Trial Locations (1)

M23 9LT

Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester

All Listed Sponsors
lead

Manchester University NHS Foundation Trust

OTHER_GOV

NCT05971979 - Therapeutic Drug Monitoring - Targeting IMproved Effectiveness | Biotech Hunter | Biotech Hunter